Identification of the murine firefly luciferase-specific CD8 T-cell epitopes

Gene Therapy

Volumn 16, Issue 3, 2009, Pages 441-447

  Limberis, M P ^a   Bell, C L ^a   Wilson, J M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; FIREFLY LUCIFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BIOLUMINESCENCE; C57BL 6 MOUSE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME SPECIFICITY; IN VIVO GENE TRANSFER; IN VIVO STUDY; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; GENE TRANSFER TECHNIQUES; LUCIFERASES, FIREFLY; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL;

ANIMALIA; MURINAE; MUS;

EID: 62549148160     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2008.177     Document Type: Article

References (14)

1. Ow DW, de Wet JR, Helinski DR, Howell SH, Wood KV, Deluca M. Transient and stable expression of the firefly luciferase gene in plant cells and transgenic plants. Science 1986; 234: 856-859.
2. Roda A, Pasini P, Mirasoli M, Michelini E, Guardigli M. Biotechnological applications of bioluminescence and chemiluminescence. Trends Biotechnol 2004; 22: 295-303.
3. Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003; 4: 346-358.
4. Oukka M, Cohen-Tannoudji M, Tanaka Y, Babinet C, Kosmatopoulos K. Medullary thymic epithelial cells induce tolerance to intracellular proteins. J Immunol 1996; 156: 968-975.
5. Han WG, Unger WW, Wauben MH. Identification of the immunodominant CTL epitope of EGFP in C57BL/6 mice. Gene Therapy 2008; 15: 700-701.
6. Gambotto A, Dworacki G, Cicinnati V, Kenniston T, Steitz J, Tuting T et al. Immunogenicity of enhanced green fluorescent protein (EGFP in BALB/c mice: Identification of an H2-Kd-restricted CTL epitope. Gene Therapy 2000; 7: 2036-2040.
7. Gavin MA, Gilbert MJ, Riddell SR, Greenberg PD, Bevan MJ. Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes. J Immunol 1993; 151: 3971-3980.
8. Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S. SYFPEITHI: Database for MHC ligands and peptide motifs. Immunogenetics 1999; 50: 213-219.
9. Parker KC, Bednarek MA, Coligan JE. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 1994; 152: 163-175.
10. Brusic V, Bajic VB, Petrovsky N. Computational methods for prediction of T-cell epitopes - a framework for modelling, testing, and applications. Methods 2004; 34: 436-443.
11. Pelte C, Cherepnev G, Wang Y, Schoenemann C, Volk HD, Kern F. Random screening of proteins for HLA-A*0201-binding nine-amino acid peptides is not sufficient for identifying CD8 T cell epitopes recognized in the context of HLA-A*0201. J Immunol 2004; 172: 6783-6789.
12. Fisher KJ, Choi H, Burda J, Chen SJ, Wilson JM. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 1996; 217: 11-22.
13. Gao GP, Yang Y, Wilson JM. Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J Virol 1996; 70: 8934-8943.
14. Miller RA. Immunodeficiency of aging: Restorative effects of phorbol ester combined with calcium ionophore. J Immunol 1986; 137: 805-808.